Research Article
Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells
Table 1
Additional clinical information DLBCL patients from GSE11318, GSE21846, GSE23501, GSE32918, and TCGA-DLBCL.
| | Clinical information | GSE11318 (N = 37) | GSE21846 (N = 29) | GSE23501 (N = 69) | GSE32918 (N = 249) | TCGA-DLBCL (N = 48) | GSE10846 (N = 420) |
| | Gender | Male (N = 20) | Not available | Male (N = 50) | Male (N = 144) | Male (N = 22) | Male (N = 224) | | Female (N = 17) | Female (N = 19) | Female (N = 105) | Female (N = 26) | Female (N = 172) | | Not available (N = 24) |
| | Median age (years) | Not available | Not available | 66 | 69 | 57 | 62 | | Overall survival status | Not available | Dead (N = 25) | Dead (N = 13) | Dead (N = 137) | Dead (N = 5) | Dead (N = 165) | | Alive (N = 4) | Alive (N = 56) | Alive (N = 112) | Alive (N = 43) | Alive (N = 249) | | Not available (N = 6) |
| | Median overall survival time (months) | Not available | 18 | 22 | 48 | 13 | 28 |
|
|
